Producing blood for transfusion using pluripotent stem cells
13 June 2018 01:30 - 02:30pm - Australia/Sydney
The news in "artificial blood” is that two research groups have transformed adult cells into stem cells that can regenerate both themselves and all the cellular components of blood. This development has been described as "the holy grail”, and offers a potential treatment for those who need bone marrow transplants and can't find appropriate donors. This is a significant milestone in regenerative medicine, and if taken to its logical conclusion, may reduce or eliminate the need for bone marrow transplants as well as red cell and platelet donations. However, these reports are a long way (many years) from clinical application in humans at present. The current state of play is presented.
Dr Rebecca Griffiths, Senior Post Doctoral Scientist - Stem Cell Ageing and Regenerative Engineering Australian Institute for Bioengineering and Nanotechnology, The University of Queensland.
• Improve awareness of the significant milestone achieved in regenerative medicine
• Understand the developments required for clinical application in humans